2ERJ - JenaLib

Asymmetric Unit (33, 66)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_074641	Y	41	S	IL2RA_HUMAN	Disease (IMD41)	796051888	A/E	Y	20	S
02	UniProt	VAR_002669	C	62	G	IL2RG_HUMAN	Disease (XSCID)	---	C/G	C	40	G
03	UniProt	VAR_002670	E	68	G	IL2RG_HUMAN	Disease (XSCID)	---	C/G	E	46	G
04	UniProt	VAR_002671	E	68	K	IL2RG_HUMAN	Disease (XSCID)	---	C/G	E	46	K
05	UniProt	VAR_021994	S	83	F	IL2RB_HUMAN	Polymorphism	2228143	B/F	S	57	F
06	UniProt	VAR_002672	N	84	K	IL2RG_HUMAN	Disease (XSCID)	---	C/G	N	62	K
07	UniProt	VAR_002673	Y	89	C	IL2RG_HUMAN	Disease (XSCID)	---	C/G	Y	67	C
08	UniProt	VAR_002674	Y	105	C	IL2RG_HUMAN	Disease (XSCID)	193922347	C/G	Y	83	C
09	UniProt	VAR_020611	E	109	K	IL2RG_HUMAN	Polymorphism	17875899	C/G	E	87	K
10	UniProt	VAR_002675	G	114	D	IL2RG_HUMAN	Disease (XSCID)	111033620	C/G	G	92	D
11	UniProt	VAR_002676	C	115	F	IL2RG_HUMAN	Disease (XSCID)	---	C/G	C	93	F
12	UniProt	VAR_002677	C	115	R	IL2RG_HUMAN	Disease (XSCID)	111033622	C/G	C	93	R
13	UniProt	VAR_002678	H	123	P	IL2RG_HUMAN	Disease (XSCID)	---	C/G	H	101	P
14	UniProt	VAR_002679	Y	125	N	IL2RG_HUMAN	Disease (XSCID)	---	C/G	Y	103	N
15	UniProt	VAR_002680	Q	144	P	IL2RG_HUMAN	Disease (XSCID)	---	C/G	Q	122	P
16	UniProt	VAR_002681	I	153	N	IL2RG_HUMAN	Disease (XSCID)	111033621	C/G	I	131	N
17	UniProt	VAR_002682	A	156	V	IL2RG_HUMAN	Disease (XSCID)	---	C/G	A	134	V
18	UniProt	VAR_002683	L	162	H	IL2RG_HUMAN	Disease (XSCID)	---	C/G	L	140	H
19	UniProt	VAR_074642	S	166	N	IL2RA_HUMAN	Disease (IMD41)	796051887	A/E	S	145	N
20	UniProt	VAR_002684	L	172	P	IL2RG_HUMAN	Disease (XSCID)	---	C/G	L	150	P
21	UniProt	VAR_002685	L	172	Q	IL2RG_HUMAN	Disease (XSCID)	---	C/G	L	150	Q
22	UniProt	VAR_002686	C	182	R	IL2RG_HUMAN	Disease (XSCID)	---	C/G	C	160	R
23	UniProt	VAR_002687	L	183	S	IL2RG_HUMAN	Disease (XSCID)	---	C/G	L	161	S
24	UniProt	VAR_002688	R	222	C	IL2RG_HUMAN	Disease (XCID)	111033618	C/G	R	200	C
25	UniProt	VAR_002689	R	224	W	IL2RG_HUMAN	Disease (XSCID)	869320658	C/G	R	202	W
26	UniProt	VAR_002690	R	226	C	IL2RG_HUMAN	Disease (XSCID)	869320659	C/G	R	204	C
27	UniProt	VAR_002691	R	226	H	IL2RG_HUMAN	Disease (XSCID)	869320660	C/G	R	204	H
28	UniProt	VAR_002692	F	227	C	IL2RG_HUMAN	Disease (XSCID)	---	C/G	F	205	C
29	UniProt	VAR_002693	L	230	P	IL2RG_HUMAN	Disease (XSCID)	---	C/G	L	208	P
30	UniProt	VAR_002694	C	231	Y	IL2RG_HUMAN	Disease (XSCID)	---	C/G	C	209	Y
31	UniProt	VAR_002695	G	232	R	IL2RG_HUMAN	Disease (XSCID)	---	C/G	G	210	R
32	UniProt	VAR_002697	W	240	C	IL2RG_HUMAN	Disease (XSCID)	---	C/G	W	218	C
33	UniProt	VAR_002698	S	241	I	IL2RG_HUMAN	Disease (XSCID)	---	C/G	S	219	I

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (33, 33)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_074641	Y	41	S	IL2RA_HUMAN	Disease (IMD41)	796051888	A	Y	20	S
02	UniProt	VAR_002669	C	62	G	IL2RG_HUMAN	Disease (XSCID)	---	C	C	40	G
03	UniProt	VAR_002670	E	68	G	IL2RG_HUMAN	Disease (XSCID)	---	C	E	46	G
04	UniProt	VAR_002671	E	68	K	IL2RG_HUMAN	Disease (XSCID)	---	C	E	46	K
05	UniProt	VAR_021994	S	83	F	IL2RB_HUMAN	Polymorphism	2228143	B	S	57	F
06	UniProt	VAR_002672	N	84	K	IL2RG_HUMAN	Disease (XSCID)	---	C	N	62	K
07	UniProt	VAR_002673	Y	89	C	IL2RG_HUMAN	Disease (XSCID)	---	C	Y	67	C
08	UniProt	VAR_002674	Y	105	C	IL2RG_HUMAN	Disease (XSCID)	193922347	C	Y	83	C
09	UniProt	VAR_020611	E	109	K	IL2RG_HUMAN	Polymorphism	17875899	C	E	87	K
10	UniProt	VAR_002675	G	114	D	IL2RG_HUMAN	Disease (XSCID)	111033620	C	G	92	D
11	UniProt	VAR_002676	C	115	F	IL2RG_HUMAN	Disease (XSCID)	---	C	C	93	F
12	UniProt	VAR_002677	C	115	R	IL2RG_HUMAN	Disease (XSCID)	111033622	C	C	93	R
13	UniProt	VAR_002678	H	123	P	IL2RG_HUMAN	Disease (XSCID)	---	C	H	101	P
14	UniProt	VAR_002679	Y	125	N	IL2RG_HUMAN	Disease (XSCID)	---	C	Y	103	N
15	UniProt	VAR_002680	Q	144	P	IL2RG_HUMAN	Disease (XSCID)	---	C	Q	122	P
16	UniProt	VAR_002681	I	153	N	IL2RG_HUMAN	Disease (XSCID)	111033621	C	I	131	N
17	UniProt	VAR_002682	A	156	V	IL2RG_HUMAN	Disease (XSCID)	---	C	A	134	V
18	UniProt	VAR_002683	L	162	H	IL2RG_HUMAN	Disease (XSCID)	---	C	L	140	H
19	UniProt	VAR_074642	S	166	N	IL2RA_HUMAN	Disease (IMD41)	796051887	A	S	145	N
20	UniProt	VAR_002684	L	172	P	IL2RG_HUMAN	Disease (XSCID)	---	C	L	150	P
21	UniProt	VAR_002685	L	172	Q	IL2RG_HUMAN	Disease (XSCID)	---	C	L	150	Q
22	UniProt	VAR_002686	C	182	R	IL2RG_HUMAN	Disease (XSCID)	---	C	C	160	R
23	UniProt	VAR_002687	L	183	S	IL2RG_HUMAN	Disease (XSCID)	---	C	L	161	S
24	UniProt	VAR_002688	R	222	C	IL2RG_HUMAN	Disease (XCID)	111033618	C	R	200	C
25	UniProt	VAR_002689	R	224	W	IL2RG_HUMAN	Disease (XSCID)	869320658	C	R	202	W
26	UniProt	VAR_002690	R	226	C	IL2RG_HUMAN	Disease (XSCID)	869320659	C	R	204	C
27	UniProt	VAR_002691	R	226	H	IL2RG_HUMAN	Disease (XSCID)	869320660	C	R	204	H
28	UniProt	VAR_002692	F	227	C	IL2RG_HUMAN	Disease (XSCID)	---	C	F	205	C
29	UniProt	VAR_002693	L	230	P	IL2RG_HUMAN	Disease (XSCID)	---	C	L	208	P
30	UniProt	VAR_002694	C	231	Y	IL2RG_HUMAN	Disease (XSCID)	---	C	C	209	Y
31	UniProt	VAR_002695	G	232	R	IL2RG_HUMAN	Disease (XSCID)	---	C	G	210	R
32	UniProt	VAR_002697	W	240	C	IL2RG_HUMAN	Disease (XSCID)	---	C	W	218	C
33	UniProt	VAR_002698	S	241	I	IL2RG_HUMAN	Disease (XSCID)	---	C	S	219	I

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (33, 33)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_074641	Y	41	S	IL2RA_HUMAN	Disease (IMD41)	796051888	E	Y	20	S
02	UniProt	VAR_002669	C	62	G	IL2RG_HUMAN	Disease (XSCID)	---	G	C	40	G
03	UniProt	VAR_002670	E	68	G	IL2RG_HUMAN	Disease (XSCID)	---	G	E	46	G
04	UniProt	VAR_002671	E	68	K	IL2RG_HUMAN	Disease (XSCID)	---	G	E	46	K
05	UniProt	VAR_021994	S	83	F	IL2RB_HUMAN	Polymorphism	2228143	F	S	57	F
06	UniProt	VAR_002672	N	84	K	IL2RG_HUMAN	Disease (XSCID)	---	G	N	62	K
07	UniProt	VAR_002673	Y	89	C	IL2RG_HUMAN	Disease (XSCID)	---	G	Y	67	C
08	UniProt	VAR_002674	Y	105	C	IL2RG_HUMAN	Disease (XSCID)	193922347	G	Y	83	C
09	UniProt	VAR_020611	E	109	K	IL2RG_HUMAN	Polymorphism	17875899	G	E	87	K
10	UniProt	VAR_002675	G	114	D	IL2RG_HUMAN	Disease (XSCID)	111033620	G	G	92	D
11	UniProt	VAR_002676	C	115	F	IL2RG_HUMAN	Disease (XSCID)	---	G	C	93	F
12	UniProt	VAR_002677	C	115	R	IL2RG_HUMAN	Disease (XSCID)	111033622	G	C	93	R
13	UniProt	VAR_002678	H	123	P	IL2RG_HUMAN	Disease (XSCID)	---	G	H	101	P
14	UniProt	VAR_002679	Y	125	N	IL2RG_HUMAN	Disease (XSCID)	---	G	Y	103	N
15	UniProt	VAR_002680	Q	144	P	IL2RG_HUMAN	Disease (XSCID)	---	G	Q	122	P
16	UniProt	VAR_002681	I	153	N	IL2RG_HUMAN	Disease (XSCID)	111033621	G	I	131	N
17	UniProt	VAR_002682	A	156	V	IL2RG_HUMAN	Disease (XSCID)	---	G	A	134	V
18	UniProt	VAR_002683	L	162	H	IL2RG_HUMAN	Disease (XSCID)	---	G	L	140	H
19	UniProt	VAR_074642	S	166	N	IL2RA_HUMAN	Disease (IMD41)	796051887	E	S	145	N
20	UniProt	VAR_002684	L	172	P	IL2RG_HUMAN	Disease (XSCID)	---	G	L	150	P
21	UniProt	VAR_002685	L	172	Q	IL2RG_HUMAN	Disease (XSCID)	---	G	L	150	Q
22	UniProt	VAR_002686	C	182	R	IL2RG_HUMAN	Disease (XSCID)	---	G	C	160	R
23	UniProt	VAR_002687	L	183	S	IL2RG_HUMAN	Disease (XSCID)	---	G	L	161	S
24	UniProt	VAR_002688	R	222	C	IL2RG_HUMAN	Disease (XCID)	111033618	G	R	200	C
25	UniProt	VAR_002689	R	224	W	IL2RG_HUMAN	Disease (XSCID)	869320658	G	R	202	W
26	UniProt	VAR_002690	R	226	C	IL2RG_HUMAN	Disease (XSCID)	869320659	G	R	204	C
27	UniProt	VAR_002691	R	226	H	IL2RG_HUMAN	Disease (XSCID)	869320660	G	R	204	H
28	UniProt	VAR_002692	F	227	C	IL2RG_HUMAN	Disease (XSCID)	---	G	F	205	C
29	UniProt	VAR_002693	L	230	P	IL2RG_HUMAN	Disease (XSCID)	---	G	L	208	P
30	UniProt	VAR_002694	C	231	Y	IL2RG_HUMAN	Disease (XSCID)	---	G	C	209	Y
31	UniProt	VAR_002695	G	232	R	IL2RG_HUMAN	Disease (XSCID)	---	G	G	210	R
32	UniProt	VAR_002697	W	240	C	IL2RG_HUMAN	Disease (XSCID)	---	G	W	218	C
33	UniProt	VAR_002698	S	241	I	IL2RG_HUMAN	Disease (XSCID)	---	G	S	219	I

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (4, 14)

Exons (18, 36)

Sequences/Alignments

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:130
 aligned with IL2RA_HUMAN | P01589 from UniProtKB/Swiss-Prot  Length:272

    Alignment length:165
                                    31        41        51        61        71        81        91       101       111       121       131       141       151       161       171       181     
          IL2RA_HUMAN    22 ELCDDDPPEIPHATFKAMAYKEGTMLNCECKRGFRRIKSGSLYMLCTGNSSHSSWDNQCQCTSSATRNTTKQVTPQPEEQKERKTTEMQSPMQPVDQASLPGHCREPPPWENEATERIYHFVVGQMVYYQCVQGYRALHRGPAESVCKMTHGKTRWTQPQLICTG 186
               SCOP domains d2erja2 A:1-64 Interleukin-2 receptor alpha chain               -----------------------------------d2erja1 A:100-165 Interleukin-2 receptor alpha chain               SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ............eeee........eee......eee......eeeee......ee.....eee.-----------------------------------...................ee.....eeeeee....eeee....eeeeee....eee....eeee. Sec.struct. author
                 SAPs(SNPs) -------------------S----------------------------------------------------------------------------------------------------------------------------N-------------------- SAPs(SNPs)
                    PROSITE SUSHI  PDB: A:1-63 UniProt: 22-84                              --------------------------------------SUSHI  PDB: A:102-165 UniProt: 123-186                           PROSITE
           Transcript 4 (1) 4---------------------------------------------------------------Exon 4.3  PDB: A:100-102 [INCOMPLETE] --------------------------------------------------------------- Transcript 4 (1)
           Transcript 4 (2) Exon 4.2a  PDB: A:1-64 UniProt: 22-86 [INCOMPLETE]               ------------------------------------Exon 4.4b  PDB: A:102-165 UniProt: 123-195 [INCOMPLETE]          Transcript 4 (2)
                 2erj A   1 ELCDDDPPEIPHATFKAMAYKEGTMLNCECKRGFRRIKSGSLYMLCTGSSSHSSWDNQCQCTSS-----------------------------------LPGHCREPPPWENEATERIYHFVVGQMVYYQCVQGYRALHRGPAESVCKMTHGKTRWTQPQLICTG 165
                                    10        20        30        40        50        60   |     -         -         -       100       110       120       130       140       150       160     
                                                                                          64                                 100

Chain B from PDB  Type:PROTEIN  Length:204
 aligned with IL2RB_HUMAN | P14784 from UniProtKB/Swiss-Prot  Length:551

    Alignment length:215
                                    41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241     
          IL2RB_HUMAN    32 SQFTCFYNSRANISCVWSQDGALQDTSCQVHAWPDRRRWNQTCELLPVSQASWACNLILGAPDSQKLTTVDIVTLRVLCREGVRWRVMAIQDFKPFENLRLMAPISLQVVHVETHRCNISWEISQASHYFERHLEFEARTLSPGHTWEEAPLLTLKQKQEWICLETLTPDTQYEFQVRVKPLQGEFTTWSPWSQPLAFRTKPAALGKDTIPWLGH 246
               SCOP domains d2erjb2 B:6-103 Interleukin-2 receptor beta chain                                                 d2erjb1 B:104-206 Interleukin-2 receptor beta chain                                                    -------------- SCOP domains
               CATH domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .eeeeee....eeeeeee.........eeeeeee......eeee.eeee..eeeeeee..............eeeeeeeee..eeeeeeeeeehhhhh......eeeeeeee....eeeeee....hhhhh..eeeeeeee....hhhhh..eee.....eeee.......eeeeeeeeee..............eeee..-----------... Sec.struct. author
                 SAPs(SNPs) ---------------------------------------------------F------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (2) ------------------------------------------------------------------------------------------------------FN3  PDB: B:108-206 UniProt: 134-234                                                                 ------------ PROSITE (2)
                PROSITE (1) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------HEMATOPO_REC_S_F1  PDB: B:172-20----------------- PROSITE (1)
           Transcript 1 (1) Exon 1.5a  PDB: B:6-42 UniProt: 30-68--------------------------Exon 1.7b  PDB: B:69-104            --------------------------------------------------------------------------------------------------------Exon 1.10a   Transcript 1 (1)
           Transcript 1 (2) ------------------------------------Exon 1.6c  PDB: B:42-68    -----------------------------------Exon 1.8b  PDB: B:104-153 UniProt: 130-179        Exon 1.9c  PDB: B:154-206 UniProt: 180-235 [INCOMPLETE] ----------- Transcript 1 (2)
                 2erj B   6 SQFTCFYNSRANISCVWSQDGALQDTSCQVHAWPDRRRWNQTCELLPVSQASWACNLILGAPDSQKLTTVDIVTLRVLCREGVRWRVMAIQDFKPFENLRLMAPISLQVVHVETHRCNISWEISQASHYFERHLEFEARTLSPGHTWEEAPLLTLKQKQEWICLETLTPDTQYEFQVRVKPLQGEFTTWSPWSQPLAFRTK-----------TGH 209
                                    15        25        35        45        55        65        75        85        95       105       115       125       135       145       155       165       175       185       195       205|        -  |  
                                                                                                                                                                                                                                  206         207

Chain C from PDB  Type:PROTEIN  Length:195
 aligned with IL2RG_HUMAN | P31785 from UniProtKB/Swiss-Prot  Length:369

    Alignment length:195
                                    63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243     
          IL2RG_HUMAN    54 TLPLPEVQCFVFNVEYMNCTWNSSSEPQPTNLTLHYWYKNSDNDKVQKCSHYLFSEEITSGCQLQKKEIHLYQTFVVQLQDPREPRRQATQMLKLQNLVIPWAPENLTLHKLSESQLELNWNNRFLNHCLEHLVQYRTDWDHSWTEQSVDYRHKFSLPSVDGQKRYTFRVRSRFNPLCGSAQHWSEWSHPIHWGS 248
               SCOP domains d2erjc1 C:32-129 Cytokine receptor common gamma chain                                             d2erjc2 C:130-226 Cytokine receptor common gamma chain                                            SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .......eeeee...eeeee............eeeeee........ee...eee....eeeeeee.hhh.....eeeeee.......eeeeeehhhh.ee....eeeeeee.....eeeeee.......eeeeeeee.......eeeee....eeee........eeeeeeeee................eee.. Sec.struct. author
             SAPs(SNPs) (1) --------G-----G---------------K----C---------------C---K----DF-------P-N------------------P--------N--V-----H---------P---------RS--------------------------------------C-W-CC--PYR-------CI------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------K----------------------------------------------R--------------------------------------------------------Q-----------------------------------------------------H---------------------- SAPs(SNPs) (2)
                PROSITE (2) ---------------------------------------------------------------------------------------------------------------------------------------------------------------HEMATOPO_REC_S_F1  PDB: C:191-224 -- PROSITE (2)
                PROSITE (3) ------------------------------------------------------------------------------------------------------FN3  PDB: C:134-226 UniProt: 156-253                                                          PROSITE (3)
           Transcript 3 (1) Exon 3.2j  PDB: C:32-68 [INCOMPLETE] -------------------------------------------------------------Exon 3.3e  PDB: C:130-176 UniProt: 152-198     Exon 3.4a  PDB: C:177-226 UniProt: 199-253         Transcript 3 (1)
           Transcript 3 (2) ------------------------------------Exon 3.3b  PDB: C:68-130 UniProt: 90-152                       ------------------------------------------------------------------------------------------------ Transcript 3 (2)
                 2erj C  32 TLPLPEVQCFVFNVEYMNCTWQSSSEPQPTNLTLHYWYKNSDNDKVQKCSHYLFSEEITSGCQLQKKEIHLYQTFVVQLQDPREPRRQATQMLKLQNLVIPWAPENLTLHKLSESQLELNWNNRFLNHCLEHLVQYRTDWDHSWTEQSVDYRHKFSLPSVDGQKRYTFRVRSRFNPLCGSAQHWSEWSHPIHWGS 226
                                    41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221

Chain D from PDB  Type:PROTEIN  Length:131
 aligned with IL2_HUMAN | P60568 from UniProtKB/Swiss-Prot  Length:153

    Alignment length:131
                                    32        42        52        62        72        82        92       102       112       122       132       142       152 
            IL2_HUMAN    23 TSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT 153
               SCOP domains d2erjd_ D: Interleukin-2 (IL-2)                                                                                                     SCOP domains
               CATH domains 2erjD00 D:3-133  [code=1.20.1250.10, no name defined]                                                                               CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author hhhhhhhhhhhhhhhhhhhhhhhhhhh.....hhhhhh...........hhhhhhhhhhhhhhhhhhhhhhh......hhhhhhhhhhhhhhhhh...............hhhhhhhhhhhhhhhhhhhhh Sec.struct. author
                 SAPs(SNPs) ----------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (2) ------------------------------------------------INTERLEUKIN_2---------------------------------------------------------------------- PROSITE (2)
               Transcript 2 Exon 2.1a  PDB: D:3-29     Exon 2.1c           Exon 2.2  PDB: D:50-97 UniProt: 70-117          Exon 2.3b  PDB: D:98-133             Transcript 2
                 2erj D   3 TSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFAQSIISTLT 133
                                    12        22        32        42        52        62        72        82        92       102       112       122       132

Chain E from PDB  Type:PROTEIN  Length:131
 aligned with IL2RA_HUMAN | P01589 from UniProtKB/Swiss-Prot  Length:272

    Alignment length:165
                                    31        41        51        61        71        81        91       101       111       121       131       141       151       161       171       181     
          IL2RA_HUMAN    22 ELCDDDPPEIPHATFKAMAYKEGTMLNCECKRGFRRIKSGSLYMLCTGNSSHSSWDNQCQCTSSATRNTTKQVTPQPEEQKERKTTEMQSPMQPVDQASLPGHCREPPPWENEATERIYHFVVGQMVYYQCVQGYRALHRGPAESVCKMTHGKTRWTQPQLICTG 186
               SCOP domains d2erje2 E:1-64 Interleukin-2 receptor alpha chain               -----------------------------------d2erje1 E:100-165 Interleukin-2 receptor alpha chain               SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ............eeee........eee......eee......eeeee......ee.....eee..----------------------------------...................ee.....eeeeee....eeee....eeeeee....eee....eeee. Sec.struct. author
                 SAPs(SNPs) -------------------S----------------------------------------------------------------------------------------------------------------------------N-------------------- SAPs(SNPs)
                    PROSITE SUSHI  PDB: E:1-63 UniProt: 22-84                              --------------------------------------SUSHI  PDB: E:102-165 UniProt: 123-186                           PROSITE
           Transcript 4 (1) 4---------------------------------------------------------------Exon 4.3  PDB: E:65-102 (gaps)        --------------------------------------------------------------- Transcript 4 (1)
           Transcript 4 (2) Exon 4.2a  PDB: E:1-65 UniProt: 22-86                            ------------------------------------Exon 4.4b  PDB: E:102-165 UniProt: 123-195 [INCOMPLETE]          Transcript 4 (2)
                 2erj E   1 ELCDDDPPEIPHATFKAMAYKEGTMLNCECKRGFRRIKSGSLYMLCTGSSSHSSWDNQCQCTSSA----------------------------------LPGHCREPPPWENEATERIYHFVVGQMVYYQCVQGYRALHRGPAESVCKMTHGKTRWTQPQLICTG 165
                                    10        20        30        40        50        60    |    -         -         -       100       110       120       130       140       150       160     
                                                                                           65                                100

Chain F from PDB  Type:PROTEIN  Length:201
 aligned with IL2RB_HUMAN | P14784 from UniProtKB/Swiss-Prot  Length:551

    Alignment length:215
                                    41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241     
          IL2RB_HUMAN    32 SQFTCFYNSRANISCVWSQDGALQDTSCQVHAWPDRRRWNQTCELLPVSQASWACNLILGAPDSQKLTTVDIVTLRVLCREGVRWRVMAIQDFKPFENLRLMAPISLQVVHVETHRCNISWEISQASHYFERHLEFEARTLSPGHTWEEAPLLTLKQKQEWICLETLTPDTQYEFQVRVKPLQGEFTTWSPWSQPLAFRTKPAALGKDTIPWLGH 246
               SCOP domains d2erjf2 F:6-103 Inter   leukin-2 receptor beta chain                                              d2erjf1 F:104-209 Interleukin-2 receptor beta chain                                                                   SCOP domains
               CATH domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .eeeeee....eeeeeee...---...eeeeeee......eee..ee....eeeeeee..............eeeeeeeee..eeeeeeeeeehhhhh......eeeeeeee...eeeeeee....hhhhh..eeeeeeee...........eee.....eeeee......eeeeeeeeee..............eeee..-----------... Sec.struct. author
                 SAPs(SNPs) ---------------------------------------------------F------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (2) ------------------------------------------------------------------------------------------------------FN3  PDB: F:108-206 UniProt: 134-234                                                                 ------------ PROSITE (2)
                PROSITE (1) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------HEMATOPO_REC_S_F1  PDB: F:172-20----------------- PROSITE (1)
           Transcript 1 (1) Exon 1.5a  PDB: F:6-42 (gaps)        --------------------------Exon 1.7b  PDB: F:69-104            --------------------------------------------------------------------------------------------------------Exon 1.10a   Transcript 1 (1)
           Transcript 1 (2) ------------------------------------Exon 1.6c  PDB: F:42-68    -----------------------------------Exon 1.8b  PDB: F:104-153 UniProt: 130-179        Exon 1.9c  PDB: F:154-206 UniProt: 180-235 [INCOMPLETE] ----------- Transcript 1 (2)
                 2erj F   6 SQFTCFYNSRANISCVWSQDG---DTSCQVHAWPDRRRWNQTCELLPVSQASWACNLILGAPDSQKLTTVDIVTLRVLCREGVRWRVMAIQDFKPFENLRLMAPISLQVVHVETHRCNISWEISQASHYFERHLEFEARTLSPGHTWEEAPLLTLKQKQEWICLETLTPDTQYEFQVRVKPLQGEFTTWSPWSQPLAFRTK-----------TGH 209
                                    15        25|   |   35        45        55        65        75        85        95       105       115       125       135       145       155       165       175       185       195       205|        -  |  
                                               26  30                                                                                                                                                                             206         207

Chain G from PDB  Type:PROTEIN  Length:195
 aligned with IL2RG_HUMAN | P31785 from UniProtKB/Swiss-Prot  Length:369

    Alignment length:195
                                    63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243     
          IL2RG_HUMAN    54 TLPLPEVQCFVFNVEYMNCTWNSSSEPQPTNLTLHYWYKNSDNDKVQKCSHYLFSEEITSGCQLQKKEIHLYQTFVVQLQDPREPRRQATQMLKLQNLVIPWAPENLTLHKLSESQLELNWNNRFLNHCLEHLVQYRTDWDHSWTEQSVDYRHKFSLPSVDGQKRYTFRVRSRFNPLCGSAQHWSEWSHPIHWGS 248
               SCOP domains d2erjg1 G:32-129 Cytokine receptor common gamma chain                                             d2erjg2 G:130-226 Cytokine receptor common gamma chain                                            SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .......eeeee...eeeee............eeeeee........ee...eeee..eeeeeeee.hhh.....eeeeee.......eeeeeehhhh.ee....eeeeeee.....eeeeee.......eeeeeeee.......eeeee....eeee........eeeeeeeee................eee.. Sec.struct. author
             SAPs(SNPs) (1) --------G-----G---------------K----C---------------C---K----DF-------P-N------------------P--------N--V-----H---------P---------RS--------------------------------------C-W-CC--PYR-------CI------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------K----------------------------------------------R--------------------------------------------------------Q-----------------------------------------------------H---------------------- SAPs(SNPs) (2)
                PROSITE (2) ---------------------------------------------------------------------------------------------------------------------------------------------------------------HEMATOPO_REC_S_F1  PDB: G:191-224 -- PROSITE (2)
                PROSITE (3) ------------------------------------------------------------------------------------------------------FN3  PDB: G:134-226 UniProt: 156-253                                                          PROSITE (3)
           Transcript 3 (1) Exon 3.2j  PDB: G:32-68 [INCOMPLETE] -------------------------------------------------------------Exon 3.3e  PDB: G:130-176 UniProt: 152-198     Exon 3.4a  PDB: G:177-226 UniProt: 199-253         Transcript 3 (1)
           Transcript 3 (2) ------------------------------------Exon 3.3b  PDB: G:68-130 UniProt: 90-152                       ------------------------------------------------------------------------------------------------ Transcript 3 (2)
                 2erj G  32 TLPLPEVQCFVFNVEYMNCTWQSSSEPQPTNLTLHYWYKNSDNDKVQKCSHYLFSEEITSGCQLQKKEIHLYQTFVVQLQDPREPRRQATQMLKLQNLVIPWAPENLTLHKLSESQLELNWNNRFLNHCLEHLVQYRTDWDHSWTEQSVDYRHKFSLPSVDGQKRYTFRVRSRFNPLCGSAQHWSEWSHPIHWGS 226
                                    41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221

Chain H from PDB  Type:PROTEIN  Length:131
 aligned with IL2_HUMAN | P60568 from UniProtKB/Swiss-Prot  Length:153

    Alignment length:131
                                    32        42        52        62        72        82        92       102       112       122       132       142       152 
            IL2_HUMAN    23 TSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT 153
               SCOP domains d2erjh_ H: Interleukin-2 (IL-2)                                                                                                     SCOP domains
               CATH domains 2erjH00 H:3-133  [code=1.20.1250.10, no name defined]                                                                               CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author hhhhhhhhhhhhhhhhhhhhhhhhhhh.....hhhhhh...........hhhhhhhhhhhhhhhhhhhhhhh......hhhhhhhhhhhhhhhhhh..............hhhhhhhhhhhhhhhhhhhhh Sec.struct. author
                 SAPs(SNPs) ----------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (2) ------------------------------------------------INTERLEUKIN_2---------------------------------------------------------------------- PROSITE (2)
               Transcript 2 Exon 2.1a  PDB: H:3-29     Exon 2.1c           Exon 2.2  PDB: H:50-97 UniProt: 70-117          Exon 2.3b  PDB: H:98-133             Transcript 2
                 2erj H   3 TSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFAQSIISTLT 133
                                    12        22        32        42        52        62        72        82        92       102       112       122       132

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (4, 14)

CATH Domains (1, 2)

Pfam Domains (0, 0)

Gene Ontology (82, 126)

Asymmetric Unit(hide GO term definitions)

Chain A,E (IL2RA_HUMAN | P01589)

molecular function
	GO:0005088	Ras guanyl-nucleotide exchange factor activity	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
	GO:0008144	drug binding	Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
	GO:0019976	interleukin-2 binding	Interacting selectively and non-covalently with interleukin-2.
	GO:0004911	interleukin-2 receptor activity	Combining with interleukin-2 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
biological process
	GO:0000165	MAPK cascade	An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
	GO:0007219	Notch signaling pathway	A series of molecular signals initiated by the binding of an extracellular ligand to the receptor Notch on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0043029	T cell homeostasis	The process of regulating the proliferation and elimination of T cells such that the total number of T cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.
	GO:0006924	activation-induced cell death of T cells	A T cell apoptotic process that occurs towards the end of the expansion phase following the initial activation of mature T cells by antigen and is triggered by T cell receptor stimulation and signals transmitted via various surface-expressed members of the TNF receptor family such as Fas ligand, Fas, and TNF and the p55 and p75 TNF receptors.
	GO:0006915	apoptotic process	A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
	GO:0008283	cell proliferation	The multiplication or reproduction of cells, resulting in the expansion of a cell population.
	GO:0007166	cell surface receptor signaling pathway	A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
	GO:0006955	immune response	Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
	GO:0002376	immune system process	Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
	GO:0006954	inflammatory response	The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
	GO:0002437	inflammatory response to antigenic stimulus	An inflammatory response to an antigenic stimulus, which can be include any number of T cell or B cell epitopes.
	GO:0038110	interleukin-2-mediated signaling pathway	A series of molecular signals initiated by the binding of interleukin-2 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0042130	negative regulation of T cell proliferation	Any process that stops, prevents or reduces the rate or extent of T cell proliferation.
	GO:0050687	negative regulation of defense response to virus	Any process that stops, prevents or reduces the rate or extent of antiviral mechanisms, thereby facilitating viral replication.
	GO:0050777	negative regulation of immune response	Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
	GO:0050728	negative regulation of inflammatory response	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
	GO:0050672	negative regulation of lymphocyte proliferation	Any process that stops, prevents or reduces the rate or extent of lymphocyte proliferation.
	GO:0043547	positive regulation of GTPase activity	Any process that activates or increases the activity of a GTPase.
	GO:0045582	positive regulation of T cell differentiation	Any process that activates or increases the frequency, rate or extent of T cell differentiation.
	GO:0042102	positive regulation of T cell proliferation	Any process that activates or increases the rate or extent of T cell proliferation.
	GO:0042104	positive regulation of activated T cell proliferation	Any process that activates or increases the rate or extent of activated T cell proliferation.
	GO:0046013	regulation of T cell homeostatic proliferation	Any process that modulates the frequency, rate or extent of resting T cell proliferation.
	GO:0002664	regulation of T cell tolerance induction	Any process that modulates the frequency, rate, or extent of T cell tolerance induction.
cellular component
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0009897	external side of plasma membrane	The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005622	intracellular	The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Chain B,F (IL2RB_HUMAN | P14784)

molecular function
	GO:0005088	Ras guanyl-nucleotide exchange factor activity	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
	GO:0004896	cytokine receptor activity	Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
	GO:0019976	interleukin-2 binding	Interacting selectively and non-covalently with interleukin-2.
	GO:0004911	interleukin-2 receptor activity	Combining with interleukin-2 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
biological process
	GO:0000165	MAPK cascade	An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
	GO:0019221	cytokine-mediated signaling pathway	A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0038110	interleukin-2-mediated signaling pathway	A series of molecular signals initiated by the binding of interleukin-2 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0030101	natural killer cell activation	The change in morphology and behavior of a natural killer cell in response to a cytokine, chemokine, cellular ligand, or soluble factor.
	GO:0043066	negative regulation of apoptotic process	Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
	GO:0043547	positive regulation of GTPase activity	Any process that activates or increases the activity of a GTPase.
	GO:0006461	protein complex assembly	The aggregation, arrangement and bonding together of a set of components to form a protein complex.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
	GO:0016032	viral process	A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
cellular component
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0009897	external side of plasma membrane	The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005887	integral component of plasma membrane	The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005622	intracellular	The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Chain C,G (IL2RG_HUMAN | P31785)

molecular function
	GO:0005088	Ras guanyl-nucleotide exchange factor activity	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
	GO:0004896	cytokine receptor activity	Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
	GO:0019976	interleukin-2 binding	Interacting selectively and non-covalently with interleukin-2.
	GO:0004911	interleukin-2 receptor activity	Combining with interleukin-2 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
	GO:0004913	interleukin-4 receptor activity	Combining with interleukin-4 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
	GO:0019982	interleukin-7 binding	Interacting selectively and non-covalently with interleukin-7.
	GO:0004917	interleukin-7 receptor activity	Combining with interleukin-7 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
biological process
	GO:0000165	MAPK cascade	An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
	GO:0019221	cytokine-mediated signaling pathway	A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0006955	immune response	Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
	GO:0038110	interleukin-2-mediated signaling pathway	A series of molecular signals initiated by the binding of interleukin-2 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0035771	interleukin-4-mediated signaling pathway	A series of molecular signals initiated by the binding of interleukin-4 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0038111	interleukin-7-mediated signaling pathway	A series of molecular signals initiated by the binding of interleukin-7 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0043547	positive regulation of GTPase activity	Any process that activates or increases the activity of a GTPase.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
	GO:0016032	viral process	A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
cellular component
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0009897	external side of plasma membrane	The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005887	integral component of plasma membrane	The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005622	intracellular	The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Chain D,H (IL2_HUMAN | P60568)

molecular function
	GO:0005088	Ras guanyl-nucleotide exchange factor activity	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
	GO:0030246	carbohydrate binding	Interacting selectively and non-covalently with any carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates.
	GO:0005125	cytokine activity	Functions to control the survival, growth, differentiation and effector function of tissues and cells.
	GO:0043208	glycosphingolipid binding	Interacting selectively and non-covalently with glycosphingolipid, a compound with residues of sphingoid and at least one monosaccharide.
	GO:0008083	growth factor activity	The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
	GO:0005134	interleukin-2 receptor binding	Interacting selectively and non-covalently with the interleukin-2 receptor.
	GO:0031851	kappa-type opioid receptor binding	Interacting selectively and non-covalently with a kappa-type opioid receptor.
	GO:0019209	kinase activator activity	Binds to and increases the activity of a kinase, an enzyme which catalyzes of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
biological process
	GO:0007186	G-protein coupled receptor signaling pathway	A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
	GO:0000165	MAPK cascade	An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
	GO:0030217	T cell differentiation	The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
	GO:0002250	adaptive immune response	An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
	GO:0007155	cell adhesion	The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
	GO:0007267	cell-cell signaling	Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered.
	GO:0006955	immune response	Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
	GO:0002376	immune system process	Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
	GO:0030101	natural killer cell activation	The change in morphology and behavior of a natural killer cell in response to a cytokine, chemokine, cellular ligand, or soluble factor.
	GO:0002903	negative regulation of B cell apoptotic process	Any process that stops, prevents, or reduces the frequency, rate, or extent of B cell apoptotic process.
	GO:0043066	negative regulation of apoptotic process	Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
	GO:0045822	negative regulation of heart contraction	Any process that stops, prevents, or reduces the frequency, rate or extent of heart contraction.
	GO:0050728	negative regulation of inflammatory response	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
	GO:0050672	negative regulation of lymphocyte proliferation	Any process that stops, prevents or reduces the rate or extent of lymphocyte proliferation.
	GO:0001933	negative regulation of protein phosphorylation	Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
	GO:0030890	positive regulation of B cell proliferation	Any process that activates or increases the rate or extent of B cell proliferation.
	GO:0043547	positive regulation of GTPase activity	Any process that activates or increases the activity of a GTPase.
	GO:0045582	positive regulation of T cell differentiation	Any process that activates or increases the frequency, rate or extent of T cell differentiation.
	GO:0042102	positive regulation of T cell proliferation	Any process that activates or increases the rate or extent of T cell proliferation.
	GO:0042104	positive regulation of activated T cell proliferation	Any process that activates or increases the rate or extent of activated T cell proliferation.
	GO:0030307	positive regulation of cell growth	Any process that activates or increases the frequency, rate, extent or direction of cell growth.
	GO:0008284	positive regulation of cell proliferation	Any process that activates or increases the rate or extent of cell proliferation.
	GO:0007204	positive regulation of cytosolic calcium ion concentration	Any process that increases the concentration of calcium ions in the cytosol.
	GO:0060999	positive regulation of dendritic spine development	Any process that increases the rate, frequency, or extent of dendritic spine development, the process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure.
	GO:0051024	positive regulation of immunoglobulin secretion	Any process that activates or increases the frequency, rate or extent of the regulated release of immunoglobulins from a cell.
	GO:0050729	positive regulation of inflammatory response	Any process that activates or increases the frequency, rate or extent of the inflammatory response.
	GO:0032729	positive regulation of interferon-gamma production	Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
	GO:0032740	positive regulation of interleukin-17 production	Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
	GO:0048304	positive regulation of isotype switching to IgG isotypes	Any process that activates or increases the frequency, rate or extent of isotype switching to IgG isotypes.
	GO:0001934	positive regulation of protein phosphorylation	Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
	GO:0045591	positive regulation of regulatory T cell differentiation	Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells.
	GO:0034105	positive regulation of tissue remodeling	Any process that activates or increases the frequency, rate, or extent of tissue remodeling.
	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0007205	protein kinase C-activating G-protein coupled receptor signaling pathway	The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds with activation of protein kinase C (PKC). PKC is activated by second messengers including diacylglycerol (DAG).
	GO:0046013	regulation of T cell homeostatic proliferation	Any process that modulates the frequency, rate or extent of resting T cell proliferation.
	GO:0045471	response to ethanol	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
cellular component
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (3, 27)

Sites (27, 27)

SS Bonds (24, 24)

Cis Peptide Bonds (2, 2)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (33, 66)

PROSITE Motifs (4, 14)

Exons (18, 36)

Sequences/Alignments

Classification and Annotation

SCOP Domains (4, 14)

CATH Domains (1, 2)

Pfam Domains (0, 0)

Gene Ontology (82, 126)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File